{"log_id": 6681714042540623791, "direction": 0, "words_result_num": 64, "words_result": [{"probability": {"variance": 1e-06, "average": 0.999107, "min": 0.996133}, "location": {"width": 187, "top": 123, "height": 23, "left": 89}, "words": "核准日期:2007年01月19日"}, {"probability": {"variance": 5.5e-05, "average": 0.996151, "min": 0.968765}, "location": {"width": 186, "top": 142, "height": 21, "left": 90}, "words": "修改日期:2008年12月30日"}, {"probability": {"variance": 0, "average": 0.999433, "min": 0.999433}, "location": {"width": 73, "top": 93, "height": 67, "left": 825}, "words": "麻"}, {"probability": {"variance": 7e-06, "average": 0.997881, "min": 0.990762}, "location": {"width": 675, "top": 174, "height": 69, "left": 169}, "words": "枸橼酸舒芬太尼注射液说明书"}, {"probability": {"variance": 1.7e-05, "average": 0.997944, "min": 0.981636}, "location": {"width": 432, "top": 240, "height": 39, "left": 282}, "words": "请仔细阅读说明书并在医师指导下使用。"}, {"probability": {"variance": 0.000768, "average": 0.985236, "min": 0.905055}, "location": {"width": 323, "top": 286, "height": 27, "left": 78}, "words": "【药品名称】通用名称:构橼酸舒芬太尼注射液"}, {"probability": {"variance": 0.006686, "average": 0.948673, "min": 0.747399}, "location": {"width": 251, "top": 310, "height": 16, "left": 175}, "words": "英文名称: Sufentanil Citrate njection"}, {"probability": {"variance": 0.000631, "average": 0.97907, "min": 0.925139}, "location": {"width": 307, "top": 326, "height": 17, "left": 175}, "words": "汉语拼音: Juyuansuan Shufentaini Zhusheye"}, {"probability": {"variance": 0.012487, "average": 0.952658, "min": 0.476358}, "location": {"width": 817, "top": 335, "height": 31, "left": 80}, "words": "【成份】本品主要成份为:响橡酸舒芬太尼:1毫升静脉注射液含75微克舒芬太尼的构酸盐,相当于50微克舒芬太尼"}, {"probability": {"variance": 0.015329, "average": 0.921453, "min": 0.482266}, "location": {"width": 625, "top": 355, "height": 27, "left": 175}, "words": "其化学名称为N-4甲氧甲基一1-2-(2-吩)乙基一4-哌啶基-N-苯基丙酰胺构橼酸盐"}, {"probability": {"variance": 0, "average": 0.999418, "min": 0.998479}, "location": {"width": 116, "top": 382, "height": 17, "left": 177}, "words": "其化学结构式为"}, {"probability": {"variance": 0.03415, "average": 0.897348, "min": 0.44429}, "location": {"width": 198, "top": 419, "height": 17, "left": 177}, "words": "分子式:C2HNOS.CHO"}, {"probability": {"variance": 9e-06, "average": 0.965353, "min": 0.96239}, "location": {"width": 67, "top": 413, "height": 15, "left": 660}, "words": " CH OCH"}, {"probability": {"variance": 0, "average": 0.865129, "min": 0.865129}, "location": {"width": 51, "top": 421, "height": 15, "left": 859}, "words": " COOH"}, {"probability": {"variance": 0.000109, "average": 0.992593, "min": 0.967778}, "location": {"width": 107, "top": 440, "height": 16, "left": 177}, "words": "分子量:578.69"}, {"probability": {"variance": 0.01601, "average": 0.940161, "min": 0.560855}, "location": {"width": 227, "top": 456, "height": 22, "left": 178}, "words": "辅料为枸橼酸、氯化钠、注射用水"}, {"probability": {"variance": 0.036128, "average": 0.842215, "min": 0.376903}, "location": {"width": 153, "top": 452, "height": 16, "left": 649}, "words": "N—COCHCH3HO"}, {"probability": {"variance": 0, "average": 0.906168, "min": 0.906168}, "location": {"width": 50, "top": 451, "height": 16, "left": 860}, "words": " COOH"}, {"probability": {"variance": 0.000197, "average": 0.991608, "min": 0.944474}, "location": {"width": 250, "top": 477, "height": 19, "left": 81}, "words": "【性状】本品为无色的澄明液体"}, {"probability": {"variance": 0, "average": 0.894832, "min": 0.894832}, "location": {"width": 54, "top": 478, "height": 15, "left": 860}, "words": " COOH"}, {"probability": {"variance": 0.022701, "average": 0.935614, "min": 0.41846}, "location": {"width": 383, "top": 492, "height": 25, "left": 82}, "words": "【适应症】用于气管内管,使月人工呼吸的全身麻醉"}, {"probability": {"variance": 3.8e-05, "average": 0.993403, "min": 0.979605}, "location": {"width": 167, "top": 514, "height": 18, "left": 188}, "words": "作为复合麻醉的镇痛用药"}, {"probability": {"variance": 7.9e-05, "average": 0.994798, "min": 0.964283}, "location": {"width": 287, "top": 530, "height": 23, "left": 188}, "words": "作为全身麻醉大手术的麻醉诱导和维持用药"}, {"probability": {"variance": 0.036928, "average": 0.875541, "min": 0.360873}, "location": {"width": 527, "top": 547, "height": 27, "left": 83}, "words": "【规格1(1)1m50ug(2)2ml100μg(3)5m250μg以舒芬太尼计"}, {"probability": {"variance": 0.007319, "average": 0.96658, "min": 0.487297}, "location": {"width": 820, "top": 562, "height": 30, "left": 95}, "words": "用法用量】本品应该根据个体反应和临床情况的不同来调整使用剂量,须考虑如下因素:患者的年龄、体重,一般情况和同"}, {"probability": {"variance": 0.004884, "average": 0.975762, "min": 0.648134}, "location": {"width": 737, "top": 582, "height": 28, "left": 178}, "words": "时使用的药物等。剂量也软决于手术难度和持续时间以及所需要的麻醉深度。在计算进一步的使用剂量时应考虑"}, {"probability": {"variance": 0.011279, "average": 0.938051, "min": 0.690187}, "location": {"width": 106, "top": 610, "height": 18, "left": 180}, "words": "初始用药的作用"}, {"probability": {"variance": 0.000226, "average": 0.991178, "min": 0.932697}, "location": {"width": 400, "top": 624, "height": 24, "left": 209}, "words": "在导麻醉期间可以加用氟利多以防止恶心和呕吐的发生。"}, {"probability": {"variance": 0.000789, "average": 0.989534, "min": 0.89682}, "location": {"width": 180, "top": 647, "height": 18, "left": 210}, "words": "请注意下述推荐的用药剂量"}, {"probability": {"variance": 0.009512, "average": 0.969417, "min": 0.533572}, "location": {"width": 690, "top": 659, "height": 27, "left": 209}, "words": "用药的途径和方法:静脉内快速推注给药或静脉内翰注给药。用药的时间间隔长短取决于手术的持续时间"}, {"probability": {"variance": 0.006589, "average": 0.970331, "min": 0.550317}, "location": {"width": 735, "top": 678, "height": 27, "left": 179}, "words": "根据个体的需要可重复给予额外的(维持)剂量1.当作为复合麻醉的一种镇痛成分进行诱导应用时:按0.1-5.0"}, {"probability": {"variance": 0.013816, "average": 0.945664, "min": 0.409467}, "location": {"width": 736, "top": 696, "height": 28, "left": 178}, "words": "μg/kg体重作静脉内推注或者加入液管中,在2~10分钟内滴完。当临床表现显示镇痛效应减弱时可按0.15-07"}, {"probability": {"variance": 0.033401, "average": 0.895649, "min": 0.35799}, "location": {"width": 455, "top": 717, "height": 27, "left": 178}, "words": "μgkg体重追加维持剂量(相于舒芬太尼注射0.2-1.0m70kg体重)"}, {"probability": {"variance": 0.021261, "average": 0.921723, "min": 0.470489}, "location": {"width": 738, "top": 734, "height": 28, "left": 180}, "words": "2.在以枸橡酸舒芬太尼为主的全身麻醉中,舒芬太尼用药总量可为8~30ug/kg,当临床表现显示镇痛效应减弱"}, {"probability": {"variance": 0.016112, "average": 0.918502, "min": 0.419004}, "location": {"width": 580, "top": 755, "height": 27, "left": 181}, "words": "时可按0.35-1.4日gkg体重追加维持剂量相当于舒芬太尼注射液0.5-2.0m70kg体重)"}, {"probability": {"variance": 0.00012, "average": 0.993606, "min": 0.96721}, "location": {"width": 104, "top": 781, "height": 16, "left": 211}, "words": "其他剂量的信息"}, {"probability": {"variance": 0.012113, "average": 0.950558, "min": 0.420704}, "location": {"width": 704, "top": 790, "height": 30, "left": 211}, "words": "在有如下疾病的病人中,如:非代偿性甲状腺功能减退、肺部疾患(尤其是那些呼吸贮备降低的疾病)、肝"}, {"probability": {"variance": 0.006895, "average": 0.970336, "min": 0.507447}, "location": {"width": 666, "top": 812, "height": 27, "left": 181}, "words": "或胃功能不全、肥胖和酒精中毒等,其用药量应酌情给予。对这些患者,建议做较长时间的术后观察"}, {"probability": {"variance": 0.013916, "average": 0.94723, "min": 0.487348}, "location": {"width": 705, "top": 830, "height": 27, "left": 212}, "words": "对体弱患考和老年病人以及已经使用过能抑制呼吸的药物的患者中,应囊少用量。而对那些接受过阿片类药"}, {"probability": {"variance": 0.015237, "average": 0.961216, "min": 0.391517}, "location": {"width": 437, "top": 851, "height": 25, "left": 181}, "words": "物治疗的有过阿片类滥用史的患者,则可能需要使用较大的剂量"}, {"probability": {"variance": 0.012546, "average": 0.951996, "min": 0.480934}, "location": {"width": 834, "top": 865, "height": 32, "left": 85}, "words": "【不良反应】典型的阿片样症状,如呼吸扣制、呼吸暂停、骨骼强直肌强直)、肌阵挛、低血压、心动过缓、恶心、呕吐"}, {"probability": {"variance": 0.027475, "average": 0.911082, "min": 0.434202}, "location": {"width": 347, "top": 891, "height": 24, "left": 182}, "words": "和晕、缩瞳和尿潴留。在注射部位有痛痒和疼痛"}, {"probability": {"variance": 0.001378, "average": 0.978147, "min": 0.86032}, "location": {"width": 256, "top": 914, "height": 18, "left": 183}, "words": "其他较少见的不良反应有:1.咽部痉挛"}, {"probability": {"variance": 0.009725, "average": 0.96658, "min": 0.4981}, "location": {"width": 605, "top": 926, "height": 27, "left": 182}, "words": "2.过敏反应和心搏停止,因在麻醉时使用其他药物,很难确定这些反应是否与舒芬太尼有关"}, {"probability": {"variance": 0.011032, "average": 0.954901, "min": 0.572286}, "location": {"width": 258, "top": 950, "height": 21, "left": 182}, "words": "3.偶尔可出现术后恢复期的呼吸再抑制"}, {"probability": {"variance": 0.011765, "average": 0.950131, "min": 0.564916}, "location": {"width": 383, "top": 968, "height": 23, "left": 86}, "words": "【禁忌】1对舒芬太尼或其他阿片类药物过敏者禁用"}, {"probability": {"variance": 0.006204, "average": 0.977305, "min": 0.492167}, "location": {"width": 737, "top": 981, "height": 29, "left": 183}, "words": "2分娩期间,或实施剖腹产手术期间婴儿剪断脐带之前,静脉内禁用本品,这是因为舒芬太尾可以引起新生儿的"}, {"probability": {"variance": 0.003649, "average": 0.953425, "min": 0.851567}, "location": {"width": 61, "top": 1011, "height": 16, "left": 183}, "words": "呼吸抑制"}, {"probability": {"variance": 0.004112, "average": 0.975727, "min": 0.599609}, "location": {"width": 739, "top": 1019, "height": 30, "left": 182}, "words": "3.本品禁用于新生儿、妊娠期和哺乳期的妇女。如果乳期妇女必须使用舒芬太尼,则应在用药后24小时方能"}, {"probability": {"variance": 0.052098, "average": 0.888987, "min": 0.378838}, "location": {"width": 91, "top": 1048, "height": 16, "left": 184}, "words": "再次哺乳儿"}, {"probability": {"variance": 0.01947, "average": 0.941763, "min": 0.432573}, "location": {"width": 651, "top": 1058, "height": 29, "left": 183}, "words": ",禁与单胺氧化酶抑制剂同时使用。在使用舒芬太尼前14天内月过单氧化酶抑制剂者,禁用本品"}, {"probability": {"variance": 0.024915, "average": 0.920856, "min": 0.49516}, "location": {"width": 139, "top": 1086, "height": 17, "left": 183}, "words": "5.急性肝卟啉症禁用"}, {"probability": {"variance": 0.00361, "average": 0.978945, "min": 0.751972}, "location": {"width": 260, "top": 1102, "height": 18, "left": 183}, "words": "6.因用其他药物而存在呼吸抑制者禁用"}, {"probability": {"variance": 0.013753, "average": 0.936433, "min": 0.63076}, "location": {"width": 214, "top": 1123, "height": 17, "left": 184}, "words": "7.患有呼吸抑制疾病的患者禁用"}, {"probability": {"variance": 0.002601, "average": 0.959461, "min": 0.867178}, "location": {"width": 215, "top": 1142, "height": 20, "left": 183}, "words": "B.低血容量症,低血压患者禁用"}, {"probability": {"variance": 0.001363, "average": 0.984593, "min": 0.868676}, "location": {"width": 154, "top": 1162, "height": 17, "left": 184}, "words": "9.重症肌无力患者禁用"}, {"probability": {"variance": 0.005491, "average": 0.97888, "min": 0.521141}, "location": {"width": 816, "top": 1173, "height": 30, "left": 89}, "words": "【注意事项】本品按麻醉药品管理,只能由受过训练的麻醉医师,在医院和其他具有气管插管和人工呼吸设施的条件下进行"}, {"probability": {"variance": 0.019818, "average": 0.942722, "min": 0.469319}, "location": {"width": 333, "top": 1198, "height": 22, "left": 186}, "words": "1,每次给药之后,都应对患者进行足够时间的监测"}, {"probability": {"variance": 0.008909, "average": 0.972279, "min": 0.481642}, "location": {"width": 738, "top": 1211, "height": 29, "left": 185}, "words": "2.在颅脑创伤和颅内压增高的患者中需要注意,避免对有脑血流量减少的患者应用快速的静脉推注方法给予阿片"}, {"probability": {"variance": 0.003685, "average": 0.982525, "min": 0.638047}, "location": {"width": 556, "top": 1232, "height": 27, "left": 185}, "words": "类药物,如本品。在这类患者中,其平均动脉压降低会偶尔伴有短期的脑灌流量减少"}, {"probability": {"variance": 0.006719, "average": 0.970989, "min": 0.501334}, "location": {"width": 738, "top": 1250, "height": 27, "left": 185}, "words": "3.深度麻醉的呼吸扣制,可持续至术后或复发,所以应对这类病人做适当的监测观察,复苏器具与药物(包括拮"}, {"probability": {"variance": 0.015414, "average": 0.942033, "min": 0.447804}, "location": {"width": 738, "top": 1269, "height": 26, "left": 185}, "words": "抗剂应准备到位。呼吸扣制往往是和剂量相关的,可用特异性拮抗剂(如:纳络酮)使其完全逆转。由于呼吸抑"}, {"probability": {"variance": 0.008104, "average": 0.968084, "min": 0.522328}, "location": {"width": 736, "top": 1287, "height": 28, "left": 186}, "words": "制持续的时间可能长干其拮抗剂的效应,有可能需要重复使用拮抗剂。麻醉期间的过度换气可能减少呼吸中枢对"}, {"probability": {"variance": 0.005035, "average": 0.967789, "min": 0.711195}, "location": {"width": 253, "top": 1313, "height": 21, "left": 186}, "words": "CO的反应,也会影响术后呼吸的恢复"}], "language": 3}